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ALFFThe blood oxygenation level-dependent (BOLD) signal is widely used for functional magnetic resonance imaging
(fMRI) of brain function in health and disease. The statistical power of fMRI group studies is signiﬁcantly hampered
by high inter-subject variance due to differences in baseline vascular physiology. Several methods have been pro-
posed to account for physiological vascularization differences between subjects and hence improve the sensitivity
in group studies. However, these methods require the acquisition of additional reference scans (such as a full rest-
ing-state fMRI session or ASL-based calibrated BOLD). We present a vascular autorescaling (VasA) method, which
does not require any additional reference scans. VasA is based on the observation that slow oscillations (b0.1 Hz)
in arterial blood CO2 levels occur naturally due to changes in respiration patterns. These oscillations yield fMRI signal
changes whose amplitudes reﬂect the blood oxygenation levels and underlying local vascularization and vascular
responsivity. VasA estimates proxies of the amplitude of these CO2-driven oscillations directly from the residuals
of task-related fMRI data without the need for reference scans. The estimates are used to scale the amplitude of
task-related fMRI responses, to account for vascular differences. The VasA maps compared well to cerebrovascular
reactivity (CVR) maps and cerebral blood volumemaps based on vascular space occupancy (VASO) measurements
in four volunteers, speaking to the physiological vascular basis of VasA. VasAwas validated in awide variety of tasks
in 138 volunteers. VasA increased t-scores by up to 30% in speciﬁc brain areas such as the visual cortex. The number
of activated voxelswas increased by up to 200% in brain areas such as the orbital frontal cortexwhile still controlling
the nominal false-positive rate. VasA fMRI outperformed previously proposed rescaling approaches based on rest-
ing-state fMRI data and can be readily applied to any task-related fMRI data set, even retrospectively.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Functional magnetic resonance imaging (fMRI) is a non-invasive
brain imaging technique that offers high spatial and temporal resolu-
tion. As such, it enables studies of brain function segregation and inte-
gration in large groups and allows for inferences about cognitive
function at the population level.
The great majority of fMRI studies are based on the blood oxygena-
tion level-dependent (BOLD) effect. Themeasured BOLD response indi-
rectly reﬂects the underlying neuronal activity (Logothetis, 2008). It
depends on a complex interaction between changes in cerebral blood
ﬂow (CBF), blood volume (CBV), and blood oxygenation (Buxton et. This is an open access article underal., 2004) that are coupled to neuronal activity (Villringer and Dirnagl,
1995; Logothetis and Wandell, 2004; Lauritzen, 2005). The baseline of
these different physiological parameters varies across different individ-
uals and across different brain regions. Such variations affect the BOLD
response amplitude and cerebrovascular reactivity (CVR) (Ainslie and
Dufﬁn, 2009). Thus, the variations increase the inter-individual variabil-
ity beyond differences in neuronal processing and consequently reduce
the statistical power of fMRI group studies (D'Esposito et al., 1999;
Huettel and McCarthy, 2001).
The low sensitivity of fMRI group studies and concomitant high
false-negative rate (Type II error) is recognized as a central issue
(Lieberman and Cunningham, 2009) since it obscures small effects as
frequently encountered in cognitive and emotion processing. Attempts
to increase the sensitivity have included improving the signal-to-noise
ratio (SNR) of fMRI by, e.g., improved radio-frequency (RF) receivethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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al., 1999; Fera et al., 2004). Post-processing techniques have also been
used to reduce the impact of physiological noise (Hutton et al., 2011),
which becomes more important with higher image SNR (Triantafyllou
et al., 2005; Hutton et al., 2011). All approaches effectively increased
the BOLD sensitivity in the individual, but the increased functional sen-
sitivity at the single subject level only partly translated into an increased
statistical power in group analyses. For example, increasing the ﬁeld
strength from 1.5 T to 3 T improved the functional sensitivity by only
up to 30% in group analyses as quantiﬁed by t-value increases (Kruger
et al., 2001; Krasnow et al., 2003; Garcia-Eulate et al., 2011), which is
much less than the improvements of ~100% observed in single subject
analyses (e.g., 1.5 T vs. 4 T in (Gati et al., 1997)). Although increasing
the number of RF receive coils and channels from 12 to 32 increased
the sensitivity in single subject analyses by about 25% (Kaza et al.,
2011), again only small and equivocal differences were found in group
analyses (Kaza et al., 2011).
The disappointingly small increases in functional sensitivity in group
studies, despite the signiﬁcant increases in sensitivity at the individual
subject level, is related to inter-individual biological variance rather
than noise in the data acquisition. Differences in structural anatomy
and functional organization across individuals are also important
sources of variation (Mueller et al., 2013), even when state of the art
inter-subject registration methods or spatial normalization methods
are used (Ashburner and Friston, 2011). This study addresses the
inter-individual differences in vascularization, which is one major
source of inter-individual biological variance. In particular, the ampli-
tude of the BOLD response varies signiﬁcantly across the population,
i.e., the same level of neuronal activity can generate different BOLD sig-
nal amplitudes in different individuals. Previous approaches mapped
and calibrated for these vascular response differences using separate
reference scans based on CBFmeasurements, hypercapnia experiments,
or resting-state fMRI experiments (rsfMRI) (Bandettini and Wong,
1997; Kannurpatti and Biswal, 2008; Kalcher et al., 2013).
All calibrationmethods address the complication that the BOLD fMRI
signal is a measure of the hemodynamic activity in the brain and serves
as an indirect indicator of the neural processes, which are the primary
focus of most functional studies. It is therefore necessary to account
for thehemodynamic responsivity to reveal the underlying neural inter-
actions andmake inferences. One establishedmethod to untangle these
interactions is calibrated BOLD (Davis et al., 1998). TheDavismodel rep-
resents the foundation of these calibration methods where the BOLD
signal is represented by a non-linear interaction between the fractional
changes in CBF and cerebral metabolic rate of oxygen (CMRO2) multi-
plied by a vascularization parameterM (Davis et al., 1998). The param-
eterM (seeMaterials andMethods, Theory), is multiplicative and hence
can be used to calibrate a voxel's BOLD signal. Because neuronal-driven
BOLD signal changes are inﬂuenced by the same vascular mechanisms
as CO2-driven changes (Bandettini and Wong, 1997; Davis et al.,
1998; Cohen et al., 2004), the M parameter can be estimated by
manipulating CO2 levels. However, this requires additional scans for
manipulating CO2 levels, often involving respiratory challenges
(e.g., Hypercapnia—increased fractional inspired carbon dioxide,
FiCO2),which are impractical inmany situations. They can beparticular-
ly stressful for patients or impossible in some disease conditions.
We propose a vascular autorescaling (VasA)method thatmaximizes
the functional sensitivity in population studies without the need for any
additional reference scans. VasA fMRI is based on the concept that
changes in breathing patterns induce slow (b0.1 Hz) variations in arte-
rial blood CO2 levels (Van den Aardweg and Karemaker, 2002; Wise et
al., 2004; Chang and Glover, 2009). The variations in blood CO2 levels
cause signiﬁcant changes in the amplitude of the BOLD signal. Wise et
al. (2004) showed that the resting-state ﬂuctuation amplitude (RSFA)
%BOLD oscillations of around 0.2%, while for 5% CO2 %BOLD signal
changes are around 2–3% (Yezhuvath et al., 2009; Donahue et al.,
2014) and similarly for breath-hold paradigms (Murphy et al., 2011)at 3 T. The innovation of VasA lies in the realization that this vasculari-
zation map may be derived from the residuals of the task-related fMRI
(tfMRI) data after removing task-related variance and slow drifts.
Previously, the power estimates of the CO2-driven low-frequency
ﬂuctuations (0.01–0.08 Hz) were extracted from rsfMRI reference
scans as a vascular marker by (Di et al., 2013; Kalcher et al.,
2013)—namedAmplitude of low-frequencyﬂuctuations (ALFF) or (con-
ceptually identical) RSFA. These estimates were then used to scale the
amplitude of tfMRI data in the same individual (Kannurpatti and
Biswal, 2008; Kannurpatti et al., 2012; Tsvetanov et al., 2015). The pro-
posed VasA method extracts similar ALFF maps directly from the tfMRI
data and thus makes additional reference scans unnecessary and, im-
portantly, can be applied to any data set, even retrospectively. We
note that the calculation of ALFF was originally introduced by Zang et
al. (2007) studying baseline activity in ADHD but is used here and in
the previous studies as a vascular marker (Di et al., 2013; Kalcher et
al., 2013; Tsvetanov et al., 2015).
We apply the VasA fMRI analysis technique to a variety of large fMRI
data sets including different tasks and acquisition protocols (Price et al.,
2010; Barch et al., 2013; Glasser et al., 2013; Larson-Prior et al., 2013).
We demonstrate that it increases sensitivity at the group level as
reﬂected in an increase of activated voxels by up to 42% for speciﬁc
tasks and an increase of local t-scores of more than 30%, while retaining
full control of false positives (Type I error). Comparisons of VasA maps
to CVR and CBV maps suggest that VasA captured the intra- and inter-
individual vascularization differences in BOLD fMRI.
Materials and methods
Theory
The BOLD fMRI signal depends on the complex coupling between
neuronal activity, changes in cerebral blood ﬂow, blood volume, and ox-
ygenation in the activated brain regions (Buxton et al., 2004). Changes
in BOLD signal amplitude can be directly related to variations in CBF,
CBV, and CMRO2 or combinations of these (Davis et al., 1998). The rela-
tionship between these parameters can be expressed analytically using
the Davis model (Davis et al., 1998). If we deﬁne the BOLD fMRI signal
change with activation (ΔSact) as the difference between the resting
state (Srest) and activated state (Sact), which is then normalized to rest-
ing state (Srest) (Davis et al., 1998; Buxton et al., 2004), the Davis model
predicts the following:
ΔSact
Srest
≈M 1−
CBFact
CBFrest
 α−β CMRO2act
CMRO2rest
 β" #
ð1Þ
where a is theGrubb's lawexponent (Grubb et al., 1974) andβ is amag-
netic ﬁeld-dependent parameter. M is a combined vascularization pa-
rameter that describes the variations that occur among different brain
regions and across different time points and individuals.M can be theo-
retically derived:
M ¼ kTEV rest ErestB0ð Þβ ð2Þ
where k is a proportionality constant, TE is the echo time, Vrest is the
baseline blood volume, Erest is the baseline oxygen extraction fraction,
and B0 is the magnetic ﬁeld strength.
The parameterM dependsmainly on the baseline deoxyhemoglobin
blood content, and thus it varies within subjects over time and within
different brain regions and between subjects (Davis et al., 1998).
M can be directly estimated from hypercapnia calibration experi-
ments, if it is assumed that changes are purely CO2 driven (i.e.,
CMRO2act = CMRO2rest) without changes in neuronal activity as pro-
posed by (Horvath et al., 1994; Yang and Krasney, 1995; Kastrup et al.,
1999; Li et al., 1999; Kannurpatti et al., 2002; Cohen et al., 2004;
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ΔSCO2
Srest
≈M 1−
CBFCO2
CBFrest
 α−β" #
ð3Þ
with ΔSCO2 being the CO2-related signal change. A previous study
(Kannurpatti and Biswal, 2008) has shown that the RSFA, estimated
from rsfMRI data and conceptually identical to ALFF, is proportional to
M and can be used as an alternative to hypercapnic experiments to de-
termine ΔSCO2 .
Since RSFA and the task-related BOLD signal change are inﬂuenced
by the same vascular physiology, M (Bandettini and Wong, 1997;
Davis et al., 1998; Cohen et al., 2004; Kannurpatti and Biswal, 2008), a
calibrated BOLD response amplitude ΔScal can be derived that is inde-
pendent of inter-individual variations in M by dividing the tfMRI re-
sponse amplitudes ΔSact by RSFA ΔSCO2 (i.e., Eq. 1 divided by Eq. 3):
ΔScal ¼
ΔSact
ΔSCO2
¼
1− CBFactCBFrest
 α−β
CMRO2act
CMRO2rest
 β 
1−
CBFCO2
CBFrest
 α−β  ð4Þ
In most tfMRI experiments, it is not a single response amplitude
ΔSact that is estimated but rather multiple response amplitudes for dif-
ferent tasks or task components using a general linear model (GLM).
Multiple task components are modeled with a set of regressors and re-
sult in the same number of estimated regression coefﬁcients. Effects of
interest are often summarized using contrasts, which are formed from
a linear combination of the regression coefﬁcients of the GLM. Contrasts
can also be calibrated by dividing by ΔSCO2 as shown in Eq. 4 since they
are linearly related to the single responses. Assuming that the CO2-relat-
ed signal change ΔSCO2 and experimental effects (e.g., task responses)
are additive, ΔSCO2 can be directly estimated from the tfMRI data as
the residuals of the GLM describing the experimental variance (i.e.,
the difference between the data andmodel prediction; see “ExtractingΔ
SCO2 from the tfMRI data”).Table 1
tfMRI HCP data (Barch et al., 2013).a
Task
Day of the taskb
No. of task blocks in each run
Social cognition
Theory of mind
(Day 2)
5
(50% of blocks TOM,c 50% of blocks random)
Relational processing (Day 2) 6
(50% of task blocks relational, 50% of task blocks co
Gambling (Day 1) 4
(50% of task blocks reward, 50% of task blocks pun
Emotion processing (Day 2) 6
(50% of task blocks face, 50% of task blocks shape)
Language (Day 2) 8
(50% of task blocks story, 50% of task blocks math)
Working memory (N-Back Task)
(Day 1)
8
(50% of task blocks 0-back, 50% of task blocks 2-ba
Motor (Day 1) 10
(20% of for each body part (5 parts in total)o)
o body parts included: Right hand, left hand, right foot, left foot, tongue.
a Adapted from Barch et al. (2013).
b Tasks were carried out in two consecutive days (Day 1 and Day 2)
c Theory of mind.Methods
fMRI experiments
Data sets for validation of VasA fMRI. Since specialized data are not re-
quired by the proposed VasA fMRI approach, we used existing data
from two different databases to assess its performance (the HCP and
the PLORAS databases). The HCP data set (Barch et al., 2013; Glasser et
al., 2013) included two sets of rsfMRI data (1200 frames per run; run
duration 14 min 33 s) acquired on two separate days and tfMRI data
sets for each participant (n=80; age range: 22–35 years old; 58 are fe-
male, 19 are male, and 3 are not reported). Details about the tfMRI data
sets used are provided in Table 1. Whole-brain multi-band single-shot
echo planar imaging (EPI) acquisitionswere acquiredwith a 32-channel
RF receive head coil on a 3-T Siemens Skyra scanner with an enhanced
gradient system. Imaging parameters were as follows: repetition time
(TR) = 720 ms, echo time (TE) = 33.1 ms, ﬂip angle = 52°, in-plane
ﬁeld of view (FOV) = 208 × 180 mm, 72 slices, 2 mm isotropic voxels,
with a multi-band acceleration factor of 8. All HCP tasks and acquisition
protocols are detailed in (Barch et al., 2013). Pre-processed HCP data
were used (as described by Glasser et al., 2013; Parker Jones et al.,
2014), ranging from 176 to 405 image volumes per time series depend-
ing on the task. The tfMRI data sets were acquired on two consecutive
days at approximately 1:30 pm each day within approximately 30 min.
The PLORAS data set (Price et al., 2010) included tfMRI data (n=58;
32 females, 26 males age range: 20–75; mean age 44). A two-dimen-
sional single-shot EPI sequence was used with 3 × 3 mm in-plane reso-
lution (TR/TE/ﬂip angle = 3080 ms/30 ms/90°, FOV= 192 mm, matrix
size = 64 × 64, 44 slices, slice thickness = 2 mm, inter-slice gap =
1 mm, 62 image volumes per time series). The PLORAS data were pre-
processed using SPM12 (as described in (Hope et al., 2014)).Rescaling of fMRI experiments. The HCP data sets were analyzed in three
different ways: standard group statistics, rescaling using a rsfMRI refer-
ence data set, and the VasA fMRI approach. Since the PLORAS data sets
did not include rsfMRI, theywere only analyzed using standard statistics
and VasA fMRI.Frames per run Run duration (min:s) Contrast used
274 3:27 Social vs baseline
Social vs random
ntrol)
232 2:56 Relational vs baseline
Relational vs match
ish)
253 3:12 Reward vs baseline
176 2:16 Face vs shape
316 3:57 Story vs math
ck)
405 5:01 2Back vs baseline
2Back vs 0-back
Faces vs baseline
Places vs baseline
Body parts vs baseline
284 3:34 Tongue vs baseline
Right hand vs baseline
Right foot vs baseline
Left hand vs Baseline
Left foot vs baseline
Hand vs foot
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we analyzed all available pre-processed data sets provided by the HCP
(Glasser et al., 2013; Larson-Prior et al., 2013) and PLORAS (Price et
al., 2010) studies using Statistical Parametric Mapping (SPM12;
Wellcome Trust Centre for Neuroimaging, UCL, London, UK), imple-
mented in MATLAB 7.14. Statistical analyses of the functional images
were performed in two steps. Each subject's pre-processed tfMRI time
series (unsmoothed data) underwent a ﬁxed effects analysis, ﬁtting
the GLM at each voxel. Each event was convolved with a canonical he-
modynamic response function. The data were high-pass ﬁltered with a
cutoff period of 128 s andwere also corrected for serial autocorrelations
using an autoregressive model. The contrasts of interest at the single-
subject (ﬁrst) level for each task were chosen as in (Barch et al., 2013)
for the HCP data (Fig. 4). The contrasts of interest for the PLORAS data
are presented in Fig. 4 (Hope et al., 2014).
ExtractingΔSCO2 from the rsfMRI reference data.ALFFmapswere comput-
ed for each subject using linearly detrended resting-state data (available
only for HCP data sets). The ALFFmap of the low-frequencypowerwith-
in the frequency band from 0.01 to 0.08 Hz was then estimated in each
voxel for each subject and smoothed using an isotropic Gaussian
smoothing kernel with 4 mm FWHM.
ExtractingΔSCO2 from the tfMRI data using VasA. For tfMRI data (HCP and
PLORAS),we used the residuals, i.e., the differences between the spatial-
ly unsmoothed tfMRI time series data and the GLM prediction. VasA
low-frequency ﬂuctuation maps were estimated from the residuals
(after they were linearly detrended) in an analogous way to ALFF esti-
mation (Zang et al., 2007). The time series for each voxel of the residuals
map was Fourier transformed and the power spectrum was obtained.
The averaged square root of the power within the frequency band of
0.01–0.08 Hz was then calculated at each voxel. The resulting low-fre-
quency ﬂuctuation maps were smoothed with an isotropic Gaussian
kernel with 4 mm FWHM.
Rescaling the BOLD response and analysis of contrasts. For each individual,
a contrast image describing the activation in each task (Fig. 4) was cre-
ated. The contrast image was then smoothed using an isotropic Gauss-
ian kernel with 4 mm FWHM and was either not calibrated (standard
approach) or calibrated, i.e., the voxel-wise contrast estimatewas divid-
ed by ΔSCO2 , i.e., the respective ALFF or VasA residual estimates. The
standard or rescaled contrasts were then entered into a second-level
analysis (i.e., uniform effect analysis using a summary statistic ap-
proach) to enable inferences at the group level. T-statistics were esti-
mated for each contrast at the group level and thresholded at p b 0.05
(with family-wise error (FWE) correction for multiple comparisons).
The t-scores (for the positive contrast) from either ALFF calibration or
VasA fMRI were plotted against the t-scores from the standard analysis
for all voxels that survived FWEcorrectionwith p b 0.05. The percentage
change in t-score due to rescaling was derived from a linear regression
of these scatter plots.
Determining false-positive rates of VasA-based fMRI analyses. Ten thou-
sand simulations were performed, each of them using the 80 subjects
from the HCP data for an arbitrarily selected motor mapping task. For
each simulation, a subject-speciﬁc random regressor was added to
each design matrix at the ﬁrst level. The random regressor was formed
by convolving normally distributed noise, Ɲ (0,1), with the canonical
hemodynamic response function (HRF) implemented in SPM12. The
convolution with the HRF was performed to closely mimic typical
BOLD responses and simulate the covariance structure of fMRI data. A
contrast testing for the explanatory power of the random regressor,
which should be zero, was speciﬁed for every subject and the null hy-
pothesis that its population mean is zero was tested at the group level
using F-statistics with p b 0.05 (FWE corrected).Optimal frequency band for estimating ﬂuctuations relevant for rescaling.
VasA maps were computed using a range of different frequency bands
by varying the upper limit from 0.02 to 1.2 Hz in increments of
0.01 Hz (whilst ﬁxing the lower frequency to 0.01 Hz). Normalization
of the BOLD response and the analysis of the contrasts were performed
as described above in a motor task from the HCP data set (Table 1). The
percentage increase in the number of activated voxels was then used as
a measure of improved sensitivity for each tested frequency band.
Comparison of VasA fMRI to CBVVASO and CVRmaps. In order to elucidate
the physiological underpinnings of the VasAmethod, VasAmaps from a
visual checkerboard stimulation experiment were compared to relative
CBVestimates fromVAscular SpaceOccupancy (VASO) acquisitions (ex-
periment 1, n=3 volunteers) and CVR estimates (experiment 2, n=1
volunteer). Both experiments were performed at 7 T at the Max Planck
Institute for Human Cognitive and Brain Sciences, Leipzig.
Experiment 1: CBV VASO. The applied fMRI sequence consisted of an in-
terleaved acquisition scheme of combined T1 and T2* weighting provid-
ing a CBVweighted VASO contrast in addition to the BOLD signals at rest
by combining a T1 preparation module with a multi-echo readout
(Huber et al., 2014). tfMRI data were acquired on a Siemens
MAGNETOM 7 T scanner (Siemens Healthcare, Erlangen, Germany) in
3 subjects (2 female, age = 22–25 years). For RF transmission and re-
ception, a 24-channel receive and a circularly polarized single-channel
transmit head coil (Nova Medical, Wilmington MA, USA) were used.
In a 10-min long fMRI run a visual checkerboard (8Hz) stimulus (30 s
rest vs. 30 s stimulation) was used to activate the visual cortex. Data
were acquired in ﬁve axial slices aligned along the calcarine sulcus
with a two-dimensional single-shot gradient-echo EPI readout. Due to
small head motion, parts of the two outermost slices were disregarded
in the analysis. The imaging parameters were TE/TI/TR = 16/1000/
1500 ms, nominal voxel size of 2 × 2 × 2 mm3, partial Fourier factor 6/
8 in the phase encoding (PE) direction.
These data were receive-ﬁeld corrected, and low-frequency ﬂuctua-
tion maps of the low-frequency power within the frequency band from
0.01 to 0.08 Hzwere extracted fromVASOdata (TR=1500ms, 255 vol-
umes) acquired at rest (normalized with respect to the mean signal to
reﬂect %CBV changes). The VasA maps were extracted from the resid-
uals after applying the GLM from BOLD checkerboard tfMRI data in
the same subjects (using the exact procedure described above for the
PLORAS/HCP data), and correlation tests were performed between the
VasA maps and the CBV maps (n = 3). The voxel-wise correlation be-
tween VasA and CBV maps was estimated across all gray matter voxels
with a signiﬁcance threshold p b 0.05.
Experiment 2: CVR. A single subject (female, age 31 years) was scanned
during a 12-min long hypercapnia task consisting of 2/5/5 min of
breathing air/5% CO2, 21% O2, and balanced N2/air. The pre-mixed gas
composition was delivered via a non-rebreathing mouthpiece connect-
ed to a three-way valve separating the inﬂow gas from the gas exhaled
by the subject. The heart rate and the respiratory gas composition were
recorded with a BIOPAC MP150 unit (BIOPAC Systems Inc, Goleta CA,
USA). Inhaled and exhaled air samples were continuously taken via a
small ﬂexible tube attached to the participant's mouthpiece and con-
nected directly to the gas sensor of the O2 and CO2 modules of the
BIOPAC system. The BIOPAC system was calibrated before the experi-
ment by adjusting the input resistances for both module sensors to
the known partial pressures of two gas mixtures. For comparison with
neural activity induced signal changes and testing VasA, a 10-min ﬂick-
ering checkerboard (8Hz) stimulation experiment (alternating 30 s rest
vs. 30 s stimulation) (same as that performed in Experiment 1)was con-
ducted right after the hypercapnia experiments.
To account for the prominent decrease of arterial arrival time during
hypercapnia and to avoid inﬂow effects of fresh (non-inverted) blood in
VASO, the blood-nulling time was reduced to TI = 765ms by adjusting
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(Huber et al., 2014).
Amedical doctorwas present in themagnet room at all times during
the breathing manipulation and was responsible for adjusting gas ﬂow
rates and monitoring heart and breathing cycles. All procedures of the
experimentswith breathingmanipulationswere approved by the Ethics
Committee of the University of Leipzig, and informed written consent
was given by the participant.
The CVR data weremotion corrected and CVRmaps were calculated
voxel by voxel in units of % signal change per mmHg end-tidal CO2
change. fMRI signal and end-tidal CO2 changes were averaged over
the period of 3 min. The ﬁrst 2 min of breathing 5% CO2 were excluded
from the analysis to minimize effects of signal transition between
steady-state rest steady-state hypercapnia.
The pulse sequence used for the CVR experimentwas the same as for
experiment 1 but with different imaging parameters: TE/TI/TR = 19/
765/1500ms, nominal voxel size of 1.5 × 1.5 × 1.5 mm3, partial Fourier
factor 5/8 in the PE direction. The VasA maps were extracted from the
residuals after applying the GLM to the BOLD checkerboard tfMRI data
as above. Correlation tests were performed between the VasA map
and the CVR map (n = 1). The voxel-wise correlation between VasA
and CVRmapswas estimated across all graymatter voxels with a signif-
icance threshold of p b 0.05.
Results
VasA fMRI increased the functional sensitivity substantially for a
range of different experiments and data acquisition schemes (Figs. 1–
4). On average ,the mean t-score increase across all activated brain
areas was approximately 10% but it reached up to 21% for particular ex-
periments (e.g., relational processing experiment in Fig. 4). VasA fMRI
yielded considerably higher t-scores (approximately 130% higher)
than the rescaling based on rsfMRI data (Fig. 4). Fig. 1 shows an example
of a group-level statisticalmap for 80 subjects for a relational processing
task from the HCP study (Barch et al., 2013) analyzedwith the standard
and two different rescaling approaches. Fig. 2 shows another example of
activations in 58 volunteers performing a speech-processing task fromFig. 1.Group-level activationmaps (p b 0.05, FWE) for a relational processing task (contrast: rela
a rsfMRI reference scan (b) and VasA fMRI (c). In the relational processing task, participants wer
at the bottom of the screen. Theywere then asked to decidewhat dimension differs across the t
(Barch et al., 2013). The contrast reﬂects the difference between the relational processing relatthe PLORAS study (Price et al., 2010). In general, the rescaling methods,
particularly VasA fMRI, increased the spatial extent of activations and t-
score values across the entire brain. In some areas, the t-score increases
relative to the standard analysis exceeded 30%, such as in the visual cor-
tex (Fig. 1c). As can be seen in Figs. 1, 2, and 4 similar increases were
achieved for different types of data sets, i.e., the increased sensitivity
afforded by VasA fMRI was independent of task and data acquisition.
Local sensitivity increases
Fig. 3 andmovie (supplementarymaterial) summarizes the sensitiv-
ity improvements thatwere achieved indifferent brain areas usingVasA
fMRI. It shows the mean t-score value increases due to VasA in each
voxel derived from all fMRI data from HCP (a) and PLORAS (b) data,
i.e., it pools over all tasks.
Spatial correlation between the resting-state ALFF and VasA maps
There was a strong correlation between ALFF and VasA measures
(Spearman's rank correlation coefﬁcient r = 0.78 for n = 80 subjects
unsmoothed). Figs. 5(a) and (b) show a single subject comparison be-
tween ALFF and VasA maps. Fig. 5(c) shows a scatter density plot for a
representative subject (unsmoothed maps measured in arbitrary units
(a.u.)). Fig. 6 shows a group comparison between ALFF (extracted
from a resting-state experiment) and VasA (extracted from tfMRI HCP
data, working memory task) maps (n= 80 subjects).
Control of false positives
Permutation analysis demonstrated that the rate of false-positive ac-
tivations was adequately controlled by VasA fMRI. It was based on
adding and testing an extra randomly generated regressor to the origi-
nal tfMRI general linear model, which should not signiﬁcantly explain
any time series variance. Simulation testing was repeated for n =
10000 permutations and resulted in false-positive activation rates of
less than the targeted 5%, i.e., 2.14% (95% conﬁdence interval: [0.0187,
0.0244]).tional processing task versus baseline) using the standard analysis (a), using rescalingwith
e presentedwith 2 pairs of objects with one pair at the top of the screen and the other pair
op pair of objects andwhether the bottompair of objects differs along the same dimension
ive to the baseline condition.
Fig. 2. Group-level activation maps (p b 0.05, FWE) for a speech-processing task using the standard analysis (a) and VasA fMRI (b). In the speech-processing task, volunteers were
instructed to say one word. The contrast reﬂects the difference between the speech processing (reading) relative to the baseline condition (marker ﬁxation).
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The maximum sensitivity improvements were achieved by
extracting the CO2-driven low-frequency ﬂuctuations from a frequency
bandwith a low cutoff at 0.01 Hz andhigh cutoff at 0.1Hz. The improve-
ments were stable over high cutoff frequencies ranging from 0.06 Hz to
0.1 Hz (average variation in number of activated voxels was 24%) for a
randomly selected HCP motor mapping task data set (Fig. 7). When
higher frequencies for the high cutoff were used (N0.1 Hz), the im-
provement was substantially lower (12%), indicating that the band-
pass ﬁlter used for VasA (0.01 Hz–0.08 Hz) captured the vascularization
differences effectively.Comparison of VasA maps to CBV VASO and CVR maps
There was a strong positive correlation between the VASO low-fre-
quency %CBV maps and the corresponding VasA maps (Fig. 8; all
r N 0.76, all p b 0.05) in all three subjects. The CVR measures wereFig. 3. Average functional sensitivity improvement using VasA for all brain areas that were teste
trasts) (b). Sensitivity increases exceeded 30% in several brain areas, e.g., the occipital cortex o
values are not shown because only 3% of all activated voxels showed a minor reduction of lesssigniﬁcantly correlated with the VasA measures in the single subject
(Fig. 9, r= 0.39, p b 0.05).
The higher sensitivity improvement due to VasA fMRI compared to
rsfMRI-based calibrationwas further investigated by quantifying the re-
producibility of ALFF maps across different time points. The coefﬁcient
of variation (CoV) of ALFF maps was signiﬁcantly smaller when they
were estimated from the same experimental run as done for VasA rather
than from separate experiments as in rsfMRI calibration. The CoV of
ALFF maps between two different runs (acquired on two consecutive
days) was 14 ± 3% and within one run was 11 ± 2%. That is, the CoV
of ALFF maps was signiﬁcantly reduced by 21% when it was estimated
from the same experimental run as opposed to when it was estimated
from two different runs (Student's paired t-test, p b 0.0001; t=−8.86).Improved sensitivity in areas with low SNR
VasA fMRI also improves functional sensitivity in areas which are
known to have very low-functional sensitivity and suffer from signald using all available tfMRI data from the HCP (19 contrasts) (a) and PLORAS data (14 con-
r the temporal pole, and were consistent across the different data sets. Note that negative
than 2%. The color bar represents fractional increases in t-score.
Fig. 4.Mean sensitivity increases due to the rsfMRI and VasA fMRI rescalingmethods compared to the standard approach. Bars indicate the relative percent increase in average t-score for
HCP (a) and PLORAS (b) data sets and the relative increase in number of activated voxels (p b 0.05, FWE) for speciﬁc contrasts of the HCP (c) and the PLORAS (d) data sets. Increases were
averaged across the entire brain, i.e., local sensitivity increases were considerably higher inmany brain areas (see Figs. 1–3). Note that the axis was shortened for the relational processing
task (*) in panel c; the total number of activated voxels increased from 159 voxels to 1139 voxels when using VasA instead of the standard analysis, resulting in 616% increase in the num-
ber of activated voxels for this task.
800 S.M. Kazan et al. / NeuroImage 124 (2016) 794–805dropout (Table 2). For example, the percentage increase in the number
of activated voxels relative to the standard approach was 66% in ventral
prefrontal cortex, 31% in the amygdala, 29% in hippocampus, and 200%
in the orbital frontal cortex.
The improved sensitivity can be leveraged in several ways. The de-
tection power of studies may be considerably increased or group sizes
may be reduced while retaining the same power. A t-score increase of
20% may translate into a reduction of approximately 40% in the group
sizewhile achieving the same statistical power, assuming simple Gauss-
ian noise.
Discussion
Functional MRI studies aim to infer the neuronal activity from the
measured BOLD response. Thus, any non-neuronal contributions or
modulations of the signal reduce the sensitivity and introduce bias.
We developed a principled rescaling technique, VasA fMRI that reduces
inter-individual vascularization variations that modulate the BOLD sig-
nal and signiﬁcantly contribute to the inter-subject variance in fMRI
group studies. Compared to standard analysis, VasA fMRI signiﬁcantlyincreases the sensitivity of group studies in terms of t-score values by
up to 30% in speciﬁc brain areas without increasing the false-positive
rate. For reference, a 20% increase is comparable to sensitivity improve-
ments due to increasing the ﬁeld strength from 1.5 T to 4 T for group
studies (Yang et al., 1999).
Relation to BOLD physiology
VasA fMRI estimates a measure of local vascularization directly from
the time series data of an fMRI experiment. The residual variance after
ﬁtting the experimental model yields an estimate of the spontaneous
low-frequency ﬂuctuations in the BOLD signal. These ﬂuctuations are
hypothesized to relate to ﬂuctuations in the arterial CO2 level and sub-
ject-speciﬁc vascularization differences such as the local blood ﬂow/vol-
ume (Wise et al., 2004). A principled derivation (see Theory section)
shows the relationship between this vascularization measure and the
established vascularization parameter (M) in the Davis model (Davis
et al., 1998), which modulates the BOLD signal multiplicatively. Thus,
the simple scaling used in VasA fMRI can address the inter-individual
differences.
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Fig. 7. Effect of the choice of the frequency band used for determining the VasA vascular
estimate. The upper cutoff of the band-pass ﬁlter was systematically varied and the im-
provement due to VasA quantiﬁed as the increase in the number of activated voxels across
the brain. The data were taken from different motor tasks from the HCP data set. 0 2 4 6 8 10
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Fig. 9. Scatter plot comparing VasA and CVR measures across the brain gray matter (r=
0.39).
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Compared to rescaling methods using separate reference scans such
as the ALFF method based on rsfMRI data (Kannurpatti and Biswal,
2008), the performance of VasA fMRI is higher (i.e., we observed consis-
tently higher t-score values andmore activated voxels for VasA in com-
parison to scaling using the rsfMRI-based ALFF measure). One
important reason may be that in VasA fMRI, the rescaling is derived
from the same time series as the tfMRI. Hence, it may more closely re-
ﬂect the current physiological state during the task than rsfMRI refer-
ence scans acquired in another session. We note that VasA relies on
the standard time series GLM-based statistical analysis and thus differs
from a recent rescaling method by (Kannurpatti and Biswal, 2008),
where the noise estimates for the statistics were determined from the
variations in percentage signal changes across the brain (but not a
time series). The method of (Kannurpatti and Biswal, 2008) may be
used for analysis of single scans and subjects, whereas VasA is tailored
towards multi-subject group analyses.
Unlike other correction methods, VasA fMRI can be applied retro-
spectively to all existing task fMRI experiments because it does not re-
quire additional and complicated reference scans. Skipping the
reference scans not only saves time but is also more comfortable for
the subject. For example, in the established hypercapnia calibration ap-
proach, volunteers need to breath CO2 enriched air (Davis et al., 1998),
which can induce adverse breathlessness, potential sensory stimulation,
and is not practical for many neurological and psychiatric conditions. As0.2 0.4 0.6 0.8
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Fig. 8. Correlation between low-frequency %CBV ﬂuctuationmaps extracted from the VASO data
the correspondingmaps extracted from the residuals after applying theGLM fromBOLD tfMRI d
1–3, respectively)).an alternative to breathing CO2 enriched air, breath-hold can be used to
induce mild hypercapnia (Kastrup et al., 1999; Thomason et al., 2005;
Handwerker et al., 2007). However, this method also induces stress in
the subject and has poor reproducibility (Chiarelli et al., 2007). More-
over, all approaches assume that brain metabolism is not affected
(Kannurpatti and Biswal, 2008; Zappe et al., 2008; Mohtasib et al.,
2012), which is controversial (Mohtasib et al., 2012). Inducing
hyperoxia with O2 enriched air instead of hypercapnia is considered
more tolerable (Chiarelli et al., 2007) but faces similar concerns regard-
ing its validity (Hoge, 2012).Considerations
The improvement in functional sensitivity due to VasA fMRI varies
across brain areas (Fig. 3). We hypothesize that this variation may be
due to different factors: (1) residual inter-individual anatomical differ-
ences may have remained even after spatial normalization and affected
different regions to varying degrees; (2) the different tasks tested here
induce activations in different brain areas and, thus, inter-individual dif-
ferences in task performance may have resulted in higher variation of
neuronal and consequent BOLD responses for some areas over others;.6 0.8
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(normalizedwith respect to the entire frequency band to reﬂect CBV changes) at rest and
ata (checker board experiment) in the three subjects at 7 T (r=0.85/0.81/0.76 for subjects
Table 2
Percent increase in the number of activated voxels (p b 0.05, FWE) using VasA fMRI com-
pared to the standard approach. Data were from the HCP study and increases were mea-
sured across different regions of interest (ROI).
ROI % Increase in number of activated voxels
Anterior cingulate 70
Inferior frontal gyrus 12
Superior temporal gyrus 9
Lateral occipital 54
Superior frontal 28
Insular 10
Middle frontal gyrus 25
SMA 14
Superior parietal 11
Hippocampus 29
VMPFC 66
Amygdala 31
Visual cortex 21
Temporal (sup and inf) 26
Orbital frontal 200
Pallidium putamen 69
Motor 10
803S.M. Kazan et al. / NeuroImage 124 (2016) 794–805(3) task-correlated changes in breathing patterns where in some com-
plex tasks, both cognitive and motor subjects may hold their breath or
increase their breathing rate during the task; and (4) individuals may
vary greatly in their resting CO2 level, and in how this changes during
breathing and deliberate manipulations of inspired gases (Prisman et
al., 2008). This may also account for some small differences between
the results for the HCP and PLORAS data (Fig. 3a vs. b). Moreover,
VasA does not capture all variance components expressed in the vascu-
larization parameterM (Eq.2).
Importantly, the sensitivity improvements were found consistent
across very different acquisition protocols (with e.g., repetition time
TR= 0.7 s vs TR= 3 s; Fig. 3) and ﬁeld strengths. As the VasA principle
was derived from fundamental BOLD signalmodels, it is expected that it
can be applied at other ﬁeld strengths as well.
VasA accounts for differences in the calibration parameterM, which
depends on baseline blood volume and baseline oxygen extraction frac-
tion (Eq. 2) and differs between subjects. VasA does not fully account for
baseline CBF differences since a CBF dependence remains even after
autorescaling, Eq. 4. Thus, it may not account for all sources of vascular
variance across subjects. The inter-subject variability of M is much
higher (Table 1 of (Davis et al., 1998), coefﬁcient of variation (CoV) of
M =0.30) than the inter-subject variability in the ratio of CBF during
hypercapnia to baseline (
CBFCO2
CBFrest
; which has CoV of 0.06). The CoV of M
is also much higher than the ratio of CBF during stimulation to baseline
(CBFactCBFrest ;which has CoV of 0.08) (Davis et al., 1998). Thus, we expect VasA
to account for themajority of vascular differences since it removes sen-
sitivity to inter-subject variance inM.
VasA fMRI is based on the assumption that variations in CO2 have no
effect on the cerebral metabolic rate. Debates concerning this hypothe-
sis have been prevalent in the ﬁeld for the last 30 years (Siesjo, 1980;
Yablonskiy, 2011); with some reporting increases (Horvath et al.,
1994; Jones et al., 2005), decreases (Zappe et al., 2008; Xu et al., 2011)
and even no changes in CMRO2 (McPherson et al., 1991; Hino et al.,
2000; Chen and Pike, 2010). Although this leads many to believe that
this disparity in results arises due to differences in experimental meth-
odology, one relationship is clear: the level of the CMRO2 changes is re-
lated to the severity of the CO2 change. Direct electrophysiological
recordings from rodent brain show clear changes in baseline neuronal
activity during severe 10–12% hypercapnia (Jones et al., 2005;
Kennerley et al., 2012) but negligible changes for smaller b5% CO2 var-
iations (Jones et al., 2005). VasA calibration relies on minor variations
in CO2 caused by natural breathing changes that are expected to be
smaller than CO2 variations arising from breathing manipulation.Therefore, one can reasonably presume variations in CMRO2 are negligi-
ble under our experimental conditions.
While VasA is believed to generally well correct for inter-regional
and inter-subject variations in vascular reactivity, it cannot account for
all sources of physiological variability. Physiological factors that could
affect VasA include vasomotion, which is a local phenomenon that re-
lates to the oscillation of the vascular diameter (i.e., rhythmic change
in diameter) at frequencies in the range from 1 to 20 min-1 (Slaaf et
al., 1988; Mayhew et al., 1996; Aalkjaer and Nilsson, 2005). The origin
of vasomotion and its physiological consequences are still not complete-
ly understood (Nilsson and Aalkjaer, 2003). Particularly, the links be-
tween neural activity and vasomotion are still unclear (Sirotin and
Das, 2009) with some papers reporting that it is not related to respira-
tion, heartbeat, or neuronal input (Schechner and Braverman, 1992;
Porret et al., 1995; Aalkjaer and Nilsson, 2005). The band of frequencies
that are related to vasomotion in small arteries are believed to be be-
tween 0.02 and 0.2 Hz (Aalkjaer and Nilsson, 2005) combination of har-
monics and slower oscillatory envelopes. As high-pass ﬁltering is a
standard preprocessing step in the fMRI data analysis, this will remove
any vasomotion-related harmonics above the typical cutoff of 0.1 Hz,
signiﬁcantly reducing any potential impact of vasomotion. VasA will
not be able to distinguish between slow oscillations related to
vasomotion or CO2 ﬂuctuations, which VasA targets. Adding to the com-
plexity, the two effects could be linked and further research is required
to untangle the two. Thus, it cannot be excluded that vasomotion effects
affect VasA estimates and their interpretation to a certain degree.
Changes in heart rate are another physiological factor thatmay affect
VasA (Shmueli et al., 2007; Chang et al., 2009). Shmueli et al. (2007) re-
ported that heart rate ﬂuctuations explain 1% of resting-state BOLD sig-
nal variance. This variance was not concentrated entirely around large
cerebral blood vessels but also included gray matter. The authors re-
ported a complex temporal relationship between heart rate and the
BOLD signal; the heart ratewas negatively correlatedwith the BOLD sig-
nal amplitude at time lags ranging from 6 to 12 s, and positively corre-
lated at time lags of 30–42 s. The heart rate ﬂuctuations may therefore
bias VasA estimates.
VasA fMRI relies on an accurate model of the experimental task-in-
duced variance; an inaccurate or incompletemodelwill result in neuronal
confounds. In this case, the VasA estimates may be inaccurate and lead to
suppression of real activation. If the model is inadequate or incomplete,
the vascular estimate may be inaccurate and lead to suppression of real
activation. Themis-speciﬁcation of themodel may result from simple ex-
perimental issues such as stimulus timing errors but also from neuronal
resting-state activity that is notmodeled. Potential task-related respirato-
ry changes may not be properly captured by the model either. Any mis-
speciﬁcation will increase the residuals of the GLM ﬁt. Since VasA uses
the power of the residuals in a speciﬁc low-frequency band, it is rather ro-
bust against mis-speciﬁcations. In the less likely case that the residuals
have a signiﬁcant component in the VasA frequency band, they will al-
ways result in a spurious increase of the VasA estimate (but no decrease).
It is plausible that for most cases of mis-speciﬁcations the error will be
similar across subjects (e.g., for a general timing error). In this case, the
percent increase in the VasA estimate will be similar across subjects and
thus the relative scaling between subjects and brain areas will be pre-
served. Thus, VasA is expected to achieve the same relative improvement
in sensitivity in this case.
In the less likely case that the mis-speciﬁcations are subject depen-
dent, reductions in sensitivity are in principle conceivable. However, in
these cases, it is likely that the entire experiment and standard analysis
approach will be generally affected. If such a case is suspected, the data
can additionally be analyzed with the standard approach since VasA is a
post-processing method and does not require tailored data acquisition.
Susceptibility artifacts may potentially inﬂuence the VasA estima-
tion. The magnitude and extent of susceptibility artifacts in basal brain
areas will change with respiration (Menon et al., 1993; Deichmann et
al., 2002; Weiskopf et al., 2006). These signal changes may be picked
804 S.M. Kazan et al. / NeuroImage 124 (2016) 794–805up by the VasA scaling procedure. Future studies using recordings of pe-
ripheral physiology and directly measuring dynamic susceptibility ef-
fects will help quantifying this effect (Hutton et al., 2008).
Although VasAmay theoretically reduce the sensitivity, our study and
results support that this case is highly unlikely. Unlike previous studies
(Kannurpatti and Biswal, 2008; Kalcher et al., 2013), we applied VasA
fMRI to a very wide spectrum of tasks and data sets (Table 1) and the
method in every single case outperformed the existing methods (i.e.,
higher t values and increased number of activated voxels). Although we
successfully applied VasA to a wide range of fMRI paradigms and a large
number of volunteers, we note that it is not completely clear how well
the method will generalize to any arbitrary task or pathophysiological
cases. Thus, we cannot fully exclude the possibility that VasA may
underperform and reduce functional sensitivity in these particular cases.
Improved sensitivity and reduced bias
VasA fMRI supports the detection of subtle group effects. For several
brain areas, the increase in sensitivity is comparable to the increase ob-
served for an increase in ﬁeld strength from 1.5 T to 4.0 T or the use of
multi-channel RF head coils instead of single-channel coils (ca. 20% t-
score increase (Yang et al., 1999)).
Vascularization may systematically vary between groups, e.g., for
different age-groups (Richter and Richter, 2003) or patient versus con-
trol groups. Thus, the group analyses might not reﬂect differences in
neural activity but rather difference in vascular responses (Thomason
et al., 2005). For such studies, VasA fMRI may capture some of the sys-
tematic differences. Although this study did not demonstrate it, VasA
promises a simple practical way of reducing the probability of
misinterpreting spurious vascular group differences as neural in origin
to a certain degree (Chugani et al., 1987; Gaillard et al., 2001).
Physiological basis of the VasA maps
The VasA estimates were correlated with CVR and VASO CBV mea-
surements, in linewith the assertion that VasA adjusts for inter-individ-
ual vascular response differences. The VasA maps correlate more
strongly with CBV-based VASO signal ﬂuctuations (in units of
%ΔVASO) acquired during resting state, suggesting that a large portion
of the VasA maps reﬂects baseline vascularization. The observed corre-
lation with CVR maps may be driven by the relationship to CBV since
CVR generally depends on CBV (Ainslie and Dufﬁn, 2009). We note
that not all sources of physiological variations could be explained.
The use of VasAmaps as a vascular scaling factor is not only supported
by our data but also by recent work by Tsvetanov et al. (2015), where the
authors showed evidence from magnetoencephalographic recordings
(MEG) of how scaling by RSFA could be used to separate neuronal from
vascular confounds in an ageing study. The authors used mediation
models to determine the variability differences between the vascular
and the neural mediators for effects of age on RSFA. They reported that
48% of the variance is explained by the vascular mediator in comparison
with 7% explained by the neural mediator (Tsvetanov et al., 2015).
Tomore comprehensively understand and robustly assess the phys-
iological underpinnings of VasA, follow-up studies will need to consider
the other components inﬂuencing the BOLD response such as CBF, CBV,
and CMRO2 (Blockley et al., 2013).
Conclusion
VasA fMRI signiﬁcantly increases functional sensitivity in group
analyses. It is straightforward to add to current analysis methods and
can be applied to any task fMRI data set irrespective of the task or acqui-
sition protocol. It does not require additional reference scans or other
complicated procedures. In our study, VasA clearly outperformed the
standard analysis and a current alternative rescaling approach based
on rsfMRI data. VasA fMRI efﬁciently improves sensitivity. If BOLDamplitude rescaling is desired, VasA reduces scanning time and stress
for patients compared to existing calibration methods. While future
studies will be required to further determine the detailed mechanisms
behind the VasA approach, the explorative comparisons between VasA
and other BOLD parameters, including CVR and CBV, suggest that VasA
is generalizable to a broad set of tasks and experimental conditions.Acknowledgments
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